Cure My Disease

Don't miss your cure!

Home News Browse Soon ready About
Log in / Sign up
← Back to home

Beijing Anjianxi Bio-medical Technology Co., Ltd.

Clinical trials sponsored by Beijing Anjianxi Bio-medical Technology Co., Ltd., explained in plain language.

Upcoming readouts

Trials from this sponsor expected to report results within the next 12 months.

  • Can an oral drug R01 fight advanced lung, stomach, and esophageal cancers? Results expected Sep 2027 (estimated)
Browse trials soon ready across all sponsors →
Not yet recruiting 1
Sort by
  • Can an oral drug R01 fight advanced lung, stomach, and esophageal cancers?

    Disease control Not yet recruiting

    This early-phase trial tests an oral drug called R01 in people with advanced squamous cell lung cancer, gastric cancer, or esophageal cancer that has progressed after standard treatment. The study aims to find the safest dose and check whether R01 can shrink tumors. Participants …

    Phase 1 • Sponsor: Beijing Anjianxi Bio-Medical Technology Co., Ltd. • Aim: Disease control

    Last updated Sep 09, 2026 16:00 UTC

Cure My Disease

Helping patients find clinical trials that match their disease.

Why was Cure my disease built?

Explore

Home News Browse Glossary About Terms of use Contact us

This is a site from Cyber and Space